These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6088459)

  • 1. Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaxime.
    Celozzi E; Pelak BA; Stapley EO; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):64-9. PubMed ID: 6088459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quaternary heterocyclylamino beta-lactams. II. The in vitro antibacterial properties of L-640,876, a new type of beta-lactam antibiotic.
    Koupal LR; Weissberger B; Shungu DL; Weinberg E; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):47-53. PubMed ID: 6088458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
    Fass RJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivities of clinically significant organisms to four cephalosporins, ampicillin and mecillinam.
    Rahman M
    Curr Med Res Opin; 1980; 7(2):96-100. PubMed ID: 6254727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
    Fass RJ
    Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
    Nachamkin I; Gibson G; Sawyer K; Samel C; Skalina D
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):87-96. PubMed ID: 3383549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.
    Neu HC
    Pharmacotherapy; 1985; 5(1):1-10. PubMed ID: 3885172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quaternary heterocyclylamino beta-lactams. VI. In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephem.
    Pelak BA; Gilfillan EC; Weissberger B; Gadebusch HH
    J Antibiot (Tokyo); 1987 Mar; 40(3):354-62. PubMed ID: 3570988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):378-89. PubMed ID: 2931927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of cefsulodin combined with cefoxitin and sulbactam against Bacteroides species.
    Fu KP; Kimble EF; Zoganas H; Konopka EA
    J Antimicrob Chemother; 1984 Mar; 13(3):257-65. PubMed ID: 6327598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M; Walsh TR; Macfarlane L; Howe RA
    J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding.
    Koupal LR; Pelak BA; Cassidy PJ; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):54-63. PubMed ID: 6381447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.